A detailed history of Inscription Capital, LLC transactions in Danaher Corp stock. As of the latest transaction made, Inscription Capital, LLC holds 1,981 shares of DHR stock, worth $457,115. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,981
Previous 1,129 75.47%
Holding current value
$457,115
Previous $282,000 95.04%
% of portfolio
0.08%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$239.25 - $280.76 $203,841 - $239,207
852 Added 75.47%
1,981 $550,000
Q2 2024

Jul 17, 2024

BUY
$235.51 - $267.98 $265,890 - $302,549
1,129 New
1,129 $282,000
Q1 2023

May 02, 2023

BUY
$239.75 - $277.0 $13,905 - $16,066
58 Added 3.96%
1,522 $383,000
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $395,296 - $2.41 Million
-1,600 Reduced 52.22%
1,464 $378,000
Q2 2022

Sep 20, 2022

BUY
$237.11 - $299.66 $379,376 - $479,456
1,600 Added 109.29%
3,064 $777,000
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $23,154 - $28,418
-90 Reduced 5.79%
1,464 $430,000
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $47,901 - $53,957
164 Added 11.8%
1,554 $512,000
Q3 2021

Nov 09, 2021

SELL
$272.21 - $332.43 $1.18 Million - $1.44 Million
-4,328 Reduced 75.69%
1,390 $423,000
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $965,143 - $1.17 Million
4,288 Added 299.86%
5,718 $1.53 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $54,187 - $62,592
255 Added 21.7%
1,430 $318,000
Q2 2020

Aug 11, 2020

BUY
$128.7 - $176.83 $151,222 - $207,775
1,175 New
1,175 $208,000
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $221,412 - $254,833
-1,773 Closed
0 $0
Q1 2019

May 16, 2019

SELL
$97.62 - $132.29 $28,895 - $39,157
-296 Reduced 14.31%
1,773 $234,000
Q4 2018

May 16, 2019

BUY
$94.85 - $109.54 $196,244 - $226,638
2,069 New
2,069 $214,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.